About HiGlance Laboratories
HiGlance Laboratories is a company based in Delhi (India) founded in 2005. It operates as a B2B and D2C. The company has 386 employees as of March 31, 2024. HiGlance Laboratories offers products and services including Tablets, Capsules, Pellets, Soft Gelatin Capsules, and Oral Liquids. HiGlance Laboratories operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Delhi, India
- Employees 386 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Higlance Laboratories Private Limited
- Date of Incorporation 11 Jun, 2003
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$8.3 M (USD)-22.41as on Mar 31, 2024
-
Net Profit
$537.21 K (USD)-78.08as on Mar 31, 2024
-
EBITDA
$872.83 K (USD)-70.47as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
386
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HiGlance Laboratories
HiGlance Laboratories offers a comprehensive portfolio of products and services, including Tablets, Capsules, Pellets, Soft Gelatin Capsules, and Oral Liquids.
Medicinal tablets for treating various health conditions like diabetes.
Encapsulated drugs for antibacterial and antifungal treatments.
Bulk formulations for nutritional and therapeutic applications.
Soft capsules for enhanced absorption of vitamins and nutrients.
Liquid medicines for cough, cold, and gastrointestinal relief.
Funding Insights of HiGlance Laboratories
Detailed funding history for HiGlance Laboratories
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HiGlance Laboratories
Investment portfolio details for HiGlance Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HiGlance Laboratories
Detailed financials for HiGlance Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Higlance Laboratories Comparisons
Peer comparison for HiGlance Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HiGlance Laboratories
HiGlance Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Detailed competitors of HiGlance Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Higlance Laboratories
Complete news archive for HiGlance Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HiGlance Laboratories
HiGlance Laboratories was founded in 2005.
HiGlance Laboratories is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
As of Mar 31, 2024, the latest employee count at HiGlance Laboratories is 386.
Annual revenue of HiGlance Laboratories is $8.3M as on Mar 31, 2024.
HiGlance Laboratories produces a range of pharmaceutical formulations including tablets, capsules, and oral liquids at facilities in Greater Noida, India. The company focuses on manufacturing high-quality drugs for categories like anti-diabetic and cardiovascular treatments. It operates with state-of-the-art production to serve domestic and international markets, participating in WHO programs and supplying chain pharmacies. Based in India, it aims to enhance global health access through affordable products.
HiGlance Laboratories's top competitors include Merck, Roivant Sciences and AbbVie.
HiGlance Laboratories offers Tablets, Capsules, Pellets, Soft Gelatin Capsules, and Oral Liquids.